School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
Amgen Korea, Seoul, Korea.
Endocrinol Metab (Seoul). 2021 Dec;36(6):1178-1188. doi: 10.3803/EnM.2021.1215. Epub 2021 Dec 16.
In South Korea, women aged 66 years are eligible for complimentary bone mineral density (BMD) screening via the National Screening Program for Transitional Ages. We aimed to evaluate the 10-year fracture risk in women receiving BMD screening between January 2008 and December 2015.
BMD was classified as normal (T-score ≥-1.0 standard deviation [SD]), osteopenia (T-score <-1.0 SD and >-2.5 SD), and osteoporosis (T score ≤-2.5 SD) from dual-energy X-ray absorptiometry. Follow-up continued from the screening date until a diagnosis for clinical fragility fracture (including sites of the vertebrae, hip, pelvis, clavicle, humerus, forearm, wrist, lower leg, and ankle), censored at the earliest date of trauma, death, or December 2017; fracture was ascertained using diagnostic codes from the National Health Insurance Service database. A multivariable Cox proportional hazard model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of fracture in women with osteopenia or osteoporosis relative to women with normal BMD.
Among the 271,197 women screened, 44.0% had osteopenia and 35.2% had osteoporosis. The 10 year cumulative incidence of fragility fractures was 31.1%, 37.5%, and 44.3% in women with normal BMD, osteopenia, and osteoporosis, respectively. Fracture risk was higher in women with osteopenia (HR, 1.31; 95% CI, 1.28 to 1.34) and osteoporosis (HR, 1.68; 95% CI, 1.64 to 1.72) than in women with normal BMD.
Women with osteopenia and women with osteoporosis, identified by the national BMD screening program, demonstrated a substantially elevated risk of fracture.
在韩国,66 岁的女性有资格通过国家过渡期筛查计划接受免费的骨密度(BMD)筛查。我们旨在评估 2008 年 1 月至 2015 年 12 月期间接受 BMD 筛查的女性 10 年骨折风险。
使用双能 X 射线吸收法将 BMD 分为正常(T 评分≥-1.0 标准差[SD])、骨量减少(T 评分<-1.0 SD 且>-2.5 SD)和骨质疏松(T 评分≤-2.5 SD)。随访从筛查日期开始,持续至临床脆性骨折(包括椎体、髋部、骨盆、锁骨、肱骨、前臂、腕部、小腿和踝部)的诊断,最早日期为创伤、死亡或 2017 年 12 月;骨折使用国家健康保险服务数据库中的诊断代码确定。使用多变量 Cox 比例风险模型来估计骨质疏松症或骨质疏松症女性相对于正常 BMD 女性的骨折风险的风险比(HR)和 95%置信区间(CI)。
在 271197 名接受筛查的女性中,44.0%患有骨量减少,35.2%患有骨质疏松症。在正常 BMD、骨量减少和骨质疏松症的女性中,10 年脆性骨折的累积发生率分别为 31.1%、37.5%和 44.3%。骨量减少(HR,1.31;95%CI,1.28 至 1.34)和骨质疏松症(HR,1.68;95%CI,1.64 至 1.72)的女性骨折风险高于正常 BMD 的女性。
通过国家 BMD 筛查计划确定的骨量减少和骨质疏松症女性骨折风险显著升高。